Impact of allopurinol use on urate concentration and cardiovascular outcome
about
A review of uric acid, crystal deposition disease, and gout.Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort studyUric acid as one of the important factors in multifactorial disorders--facts and controversies.Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout.Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan.Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort studyAllopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control StudyXanthine oxidase and uric Acid in atrial fibrillation.Allopurinol and the risk of stroke in older adults receiving medicareHyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studiesIs urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study.Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects.Uric acid in heart failure: a biomarker or therapeutic target?Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.Recent advances in understanding and managing goutManagement of gout in the real world: current practice versus guideline recommendations.Nitroso-redox imbalance affects cardiac structure and function.Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor.Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease.Serendipity: How the search for meaning of serum uric acid might lead to the repurposing of an old drug in patients with cardiovascular disease.Physiology of Hyperuricemia and Urate-Lowering Treatments.Serum uric acid levels and hyperuricemia in patients with psoriasis: a hospital-based cross-sectional study
P2860
Q30619265-D63DFB18-5F06-42AD-849B-9BF660AC2A2CQ33712386-8F25E662-6934-4698-80B0-18EF8F8EFD3EQ33773142-E9A1572E-29E1-4481-99A7-29CB7B2CC210Q33896768-B915A26E-0CE7-47D5-B745-2A072561DF44Q34484081-01AFCDA6-CD49-4B2F-83A6-FE1359DC7BCBQ34637721-1348A646-9468-4E68-B1DE-54B552F75A48Q35065173-B0E2067A-9CB5-4491-996E-A5B1049431DAQ35121532-A92DC168-A0D5-4BAA-B92A-82EBE4E88D76Q35642254-020B5343-F42D-46CD-9FFA-9591CEF5779BQ35889954-CAB7CA72-8230-480F-88F5-1884701C0DD4Q35985640-1F3641EF-67AE-4E76-9C35-B454C468A5DDQ36125528-31E2A146-9DCF-4986-985B-985BE8B834ADQ36177428-37E78EB3-0439-44E0-957B-30356A871E38Q36233048-82CC1B20-7A7F-4D20-A765-D271E3F50244Q36306524-EB757E37-E8C8-4B95-8D39-79C169F9EDEDQ37070180-5629CA4D-59B1-4D13-8F41-B74DDFEDFED8Q37597051-08ECF5B5-2AFE-4029-8C45-197583D02745Q38010013-00B3984E-D1FB-49FE-90F0-98B50B7D79BFQ38853112-883ACBB0-87AA-4B4A-9636-F07728F4ABEDQ39207801-ECA8A12E-4C97-4B4A-B9E0-B4447E2A4ED3Q40291328-EA25D92F-6DD2-4EB8-B758-180DD8C6B263Q42668752-D2FEBBF5-AE39-4EF0-BB9D-58D0D87A24FEQ47150749-9F02EDCD-909F-40D1-B34C-740833F2F20DQ47808087-C660372F-EBAA-49CF-B918-532DA1A7094BQ49830835-961B8215-142B-471B-89F5-5A30B549DE59Q55163806-5DA201B3-2895-43B8-B32F-E2C0F65DC413Q58777602-48DE45B0-E074-4499-B0E2-2512A9FFFB53
P2860
Impact of allopurinol use on urate concentration and cardiovascular outcome
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of allopurinol use on urate concentration and cardiovascular outcome
@ast
Impact of allopurinol use on urate concentration and cardiovascular outcome
@en
Impact of allopurinol use on urate concentration and cardiovascular outcome
@nl
type
label
Impact of allopurinol use on urate concentration and cardiovascular outcome
@ast
Impact of allopurinol use on urate concentration and cardiovascular outcome
@en
Impact of allopurinol use on urate concentration and cardiovascular outcome
@nl
prefLabel
Impact of allopurinol use on urate concentration and cardiovascular outcome
@ast
Impact of allopurinol use on urate concentration and cardiovascular outcome
@en
Impact of allopurinol use on urate concentration and cardiovascular outcome
@nl
P2860
P50
P1476
Impact of allopurinol use on urate concentration and cardiovascular outcome
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2010.03887.X
P407
P577
2011-04-01T00:00:00Z